Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudia Alicata

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Immunology Letters|July 14, 2023
Human toll-like receptor 8 (TLR8) in NK cells: Implication for cancer immunotherapyIrene Veneziani, Claudia Alicata, Lorenzo Moretta, et al.
Biomedicines|January 21, 2023
The Latest Approach of Immunotherapy with Endosomal TLR Agonists Improving NK Cell Function: An OverviewIrene Veneziani, Claudia Alicata, Lorenzo Moretta, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 21, 2023
Determining Endosomal Toll-Like Receptors Gene Expression in NK Cells After Stimulation with Specific AgonistsClaudia Alicata, Irene Veneziani, Biancamaria Ricci, et al.
Frontiers in Immunology|March 3, 2020
An Anti-inflammatory microRNA Signature Distinguishes Group 3 Innate Lymphoid Cells From Natural Killer Cells in Human DeciduaAndrea Pelosi, Claudia Alicata, Nicola Tumino, et al.
Frontiers in Immunology|June 13, 2017
KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell LicensingSimona Carlomagno, Michela Falco, Maria Bono, et al.
HLA|April 12, 2022
Epitope characterization of a monoclonal antibody that selectively recognizes KIR2DL1 allotypesMichela Falco, Raffaella Meazza, Claudia Alicata, et al.
Biomedicines|June 27, 2024
A De Novo <i>CaSR</i> Missense Variant in Combination with Two Inherited Missense Variants in <i>CFTR</i> and <i>SPINK1</i> Detected in a Patient with Chronic PancreatitisPiera Bontempo, Cecilia Surace, Lucia Menale, et al.
Oncoimmunology|January 3, 2024
The anti-inflammatory cytokine IL-37 improves the NK cell-mediated anti-tumor responseNadine Landolina, Francesca Romana Mariotti, Andrea Pelosi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2014
Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord bloodMariella Della Chiesa, Michela Falco, Alice Bertaina, et al.
Journal for Immunotherapy of Cancer|January 29, 2022
Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56<sup>bright</sup>CD16<sup>-</sup> subsetIrene Veneziani, Claudia Alicata, Andrea Pelosi, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Immunology Letters|July 14, 2023
Human toll-like receptor 8 (TLR8) in NK cells: Implication for cancer immunotherapyIrene Veneziani, Claudia Alicata, Lorenzo Moretta, et al.
Biomedicines|January 21, 2023
The Latest Approach of Immunotherapy with Endosomal TLR Agonists Improving NK Cell Function: An OverviewIrene Veneziani, Claudia Alicata, Lorenzo Moretta, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 21, 2023
Determining Endosomal Toll-Like Receptors Gene Expression in NK Cells After Stimulation with Specific AgonistsClaudia Alicata, Irene Veneziani, Biancamaria Ricci, et al.
Frontiers in Immunology|March 3, 2020
An Anti-inflammatory microRNA Signature Distinguishes Group 3 Innate Lymphoid Cells From Natural Killer Cells in Human DeciduaAndrea Pelosi, Claudia Alicata, Nicola Tumino, et al.
Frontiers in Immunology|June 13, 2017
KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell LicensingSimona Carlomagno, Michela Falco, Maria Bono, et al.
HLA|April 12, 2022
Epitope characterization of a monoclonal antibody that selectively recognizes KIR2DL1 allotypesMichela Falco, Raffaella Meazza, Claudia Alicata, et al.
Biomedicines|June 27, 2024
A De Novo <i>CaSR</i> Missense Variant in Combination with Two Inherited Missense Variants in <i>CFTR</i> and <i>SPINK1</i> Detected in a Patient with Chronic PancreatitisPiera Bontempo, Cecilia Surace, Lucia Menale, et al.
Oncoimmunology|January 3, 2024
The anti-inflammatory cytokine IL-37 improves the NK cell-mediated anti-tumor responseNadine Landolina, Francesca Romana Mariotti, Andrea Pelosi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2014
Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord bloodMariella Della Chiesa, Michela Falco, Alice Bertaina, et al.
Journal for Immunotherapy of Cancer|January 29, 2022
Toll-like receptor 8 agonists improve NK-cell function primarily targeting CD56<sup>bright</sup>CD16<sup>-</sup> subsetIrene Veneziani, Claudia Alicata, Andrea Pelosi, et al.
Pageof 2